These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13638834)

  • 21. Phenformin (phenethylbiguanide) in the treatment of diabetes mellitus: a preliminary report.
    BREIDAHL HD
    Med J Aust; 1961 Dec; 48(2)():1041-3. PubMed ID: 13872769
    [No Abstract]   [Full Text] [Related]  

  • 22. The management of the obese diabetic patient.
    Albu J; Raja-Khan N
    Prim Care; 2003 Jun; 30(2):465-91. PubMed ID: 14567159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acarbose, a reliable therapeutic principle].
    Laube H
    Med Klin (Munich); 2003 Oct; 98 Suppl 1():2-6. PubMed ID: 14694834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standards of diabetic control.
    Duncan GG; Duncan TG
    Med Clin North Am; 1966 Sep; 50(5):1371-83. PubMed ID: 5971576
    [No Abstract]   [Full Text] [Related]  

  • 25. Diabetic control in community care. The use of clinical evaluation and hemoglobin A1.
    Agardh CD; Scherstén B
    Scand J Prim Health Care; 1985 Feb; 3(1):15-8. PubMed ID: 3903904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of phenethylbiguanide (DBI) on the fasting blood sugar and the glucide assimilation coefficient of of the normal rat during chronic treatment].
    BALASSE E
    Rev Immunol Ther Antimicrob; 1961 Nov; 6():913-6. PubMed ID: 13864262
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
    Buse JB; Bergenstal RM; Glass LC; Heilmann CR; Lewis MS; Kwan AY; Hoogwerf BJ; Rosenstock J
    Ann Intern Med; 2011 Jan; 154(2):103-12. PubMed ID: 21138825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-insulin-dependent diabetes mellitus.
    Flick M; Schumann L
    J Am Acad Nurse Pract; 1997 Jul; 9(7):337-44; quiz 346-7. PubMed ID: 9274257
    [No Abstract]   [Full Text] [Related]  

  • 29. [Metformin efficacious in poorly controlled diabetes mellitus type 2].
    Stades AM; Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1897-900. PubMed ID: 11045134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type II diabetes: tips for managing your older patients.
    Bohannon NJ; Jack DB
    Geriatrics; 1996 Mar; 51(3):28-35. PubMed ID: 8641590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of exercise training on doses of oral agents and insulin.
    Fujinuma H; Abe R; Yamazaki T; Seino H; Kikuchi H; Hoshino T; Hirano R; Yoshida S
    Diabetes Care; 1999 Oct; 22(10):1754-5. PubMed ID: 10526756
    [No Abstract]   [Full Text] [Related]  

  • 32. [Metabolic control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide].
    Pujante Alarcón P; Hellín Gil MD; Román LM; Ferrer Gómez M; García Zafra MV; Tébar Massó J
    Med Clin (Barc); 2012 Dec; 139(13):572-8. PubMed ID: 22209597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of glycaemic control in stable type 2 black South African diabetics attending a peri-urban clinic.
    Erasmus RT; Blanco Blanco E; Okesina AB; Gqweta Z; Matsha T
    Postgrad Med J; 1999 Oct; 75(888):603-6. PubMed ID: 10621901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical factors associated with the occurrence of nausea and vomiting in type 2 diabetes patients treated with glucagon-like peptide-1 receptor agonists.
    Shiomi M; Takada T; Tanaka Y; Yajima K; Isomoto A; Sakamoto M; Otori K
    J Diabetes Investig; 2019 Mar; 10(2):408-417. PubMed ID: 30033675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy, dose-response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic control despite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies.
    Fujioka K; Brazg RL; Raz I; Bruce S; Joyal S; Swanink R; Pans M
    Diabetes Obes Metab; 2005 Jan; 7(1):28-39. PubMed ID: 15642073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein abnormalities in well-treated type II diabetic patients.
    Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
    Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A four-year follow-up study on the incidence of diabetic retinopathy in older onset diabetes mellitus.
    Agardh E; Agardh CD; Koul S; Torffvit O
    Diabet Med; 1994 Apr; 11(3):273-8. PubMed ID: 8033526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of exenatide monotherapy in obese patients with newly diagnosed type 2 diabetes: a randomized, 26 weeks metformin-controlled, parallel-group study.
    Yuan GH; Song WL; Huang YY; Guo XH; Gao Y
    Chin Med J (Engl); 2012 Aug; 125(15):2677-81. PubMed ID: 22931974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HbA(1c) and glycemic profile, basal- and post-treatment with Miglitol, in an area with a Mediterranean diet.
    Faure E; Pallardo LF; Mesa J; Puig-Domingo M; García-Mayor R; Benito P; Ravella R; Artés M; López JS;
    Diabetes Care; 2002 Oct; 25(10):1896-8. PubMed ID: 12351510
    [No Abstract]   [Full Text] [Related]  

  • 40. Summaries for patients. Exenatide or insulin glargine for suboptimally controlled diabetes?
    Ann Intern Med; 2005 Oct; 143(8):I30. PubMed ID: 16230718
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.